Please enclosed tender announcement

Order Above 5pct RevenueGovt Defence OrderBusiness Updates View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+6.5%Reaction day

₹215.00

prior close

₹218.00

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.6%+7.1% vs market

Medical Equipment & Supplies peers, median of 13sector-1.6%+8.1% vs sector

On the reaction day the stock moved 7.1 pts more than Nifty Microcap 250 and 8.1 pts more than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+6.5-0.6+7.1-1.6+8.1

Next day

+0.5-1.5+2.0-1.4+1.8

-1.9-1.8-0.0-2.3+0.4

-4.7-0.6-4.1-2.0-2.7

—+0.8—-2.9—

+1.4+0.8+0.5-2.1+3.5

-8.6-0.2-8.4-2.1-6.5

15d

-16.8+1.1-17.9-3.1-13.7

-27.9-3.5-24.4-8.1-19.8

-18.6-3.2-15.4-11.1-7.5

-27.9-12.8-15.1-21.4-6.4

UpDownMarket · Nifty Microcap 250Sector · Medical Equipment & Supplies peers, median of 13Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Royal Sense Limited informed BSE that TTG Innovations Private Limited (which is being merged into Royal Sense and has received BSE NOC for the Scheme of Arrangement) has been awarded a significant tender by the Central Procurement Agency, Directorate General of Health Services (GNCT of Delhi). The order is for the supply of various surgical sutures including absorbable, non-absorbable, monofilament, braided, and specialty sutures to be executed over 2 years. The Board expects this tender to boost the Company's sales by up to ₹100 Crore. The order is domestic, awarded by a government health body, and there is no related-party interest involved.

Likely market impact

A potential ₹100 Crore sales boost from a government health tender is materially positive for Royal Sense, likely supporting revenue growth and stock sentiment, though execution over 2 years and pending merger completion are key factors to watch.